| Primary |
| Drug Use For Unknown Indication |
53.4% |
| Depression |
5.5% |
| Hypertension |
4.1% |
| Multiple Myeloma |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Type 2 Diabetes Mellitus |
4.1% |
| Anxiety |
2.7% |
| Atrial Fibrillation |
2.7% |
| Diabetes Mellitus |
2.7% |
| Rheumatic Disorder |
2.7% |
| Acute Tonsillitis |
1.4% |
| Bipolar Disorder |
1.4% |
| Cardiac Failure |
1.4% |
| Epinephrine Increased |
1.4% |
| Essential Hypertension |
1.4% |
| Hyperuricaemia |
1.4% |
| Influenza |
1.4% |
| Medication Error |
1.4% |
| Migraine |
1.4% |
| Open Angle Glaucoma |
1.4% |
|
| Hallucinations, Mixed |
9.5% |
| Alanine Aminotransferase Increased |
4.8% |
| Cardiac Failure |
4.8% |
| Condition Aggravated |
4.8% |
| Dehydration |
4.8% |
| Hyperlactacidaemia |
4.8% |
| Hypoglycaemia Neonatal |
4.8% |
| Hypotension |
4.8% |
| Jaundice |
4.8% |
| Medication Error |
4.8% |
| Neutropenia |
4.8% |
| Oedema |
4.8% |
| Optic Neuritis |
4.8% |
| Pain |
4.8% |
| Pulmonary Arterial Hypertension |
4.8% |
| Pyrexia |
4.8% |
| Renal Failure Acute |
4.8% |
| Somnolence |
4.8% |
| Suicidal Ideation |
4.8% |
| Toxic Skin Eruption |
4.8% |
|
| Secondary |
| Hypertension |
26.2% |
| Product Used For Unknown Indication |
22.3% |
| Drug Use For Unknown Indication |
16.4% |
| Migraine |
7.0% |
| Diabetes Mellitus |
4.7% |
| Convulsion |
3.9% |
| Type 2 Diabetes Mellitus |
3.5% |
| Atrial Fibrillation |
2.0% |
| Epilepsy |
2.0% |
| Gastritis Prophylaxis |
1.6% |
| Migraine Prophylaxis |
1.6% |
| Blood Pressure |
1.2% |
| Depression |
1.2% |
| Influenza Like Illness |
1.2% |
| Pulmonary Embolism |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Back Pain |
0.8% |
| Breast Cancer Metastatic |
0.8% |
| Dyslipidaemia |
0.8% |
| Erysipelas |
0.8% |
|
| Hallucinations, Mixed |
8.7% |
| Muscle Haemorrhage |
8.7% |
| Renal Failure Acute |
8.7% |
| Ventricular Tachycardia |
8.7% |
| Vomiting |
8.7% |
| Pain |
6.5% |
| Pancreatic Enzymes Increased |
6.5% |
| Toxic Skin Eruption |
6.5% |
| Hyperlactacidaemia |
4.3% |
| Oedema |
4.3% |
| Renal Failure |
4.3% |
| Sepsis |
4.3% |
| Visual Acuity Reduced |
4.3% |
| Abnormal Loss Of Weight |
2.2% |
| Arthralgia |
2.2% |
| Condition Aggravated |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Erythema Multiforme |
2.2% |
| Foetal Growth Retardation |
2.2% |
| Hyponatraemia |
2.2% |
|
| Concomitant |
| Hypertension |
31.9% |
| Product Used For Unknown Indication |
12.1% |
| Drug Use For Unknown Indication |
7.3% |
| Atrial Fibrillation |
5.0% |
| Insomnia |
4.5% |
| Menopause |
4.5% |
| Diabetes Mellitus |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Cerebral Infarction |
3.0% |
| Osteoporosis |
2.8% |
| Constipation |
2.4% |
| Headache |
2.4% |
| Premedication |
2.4% |
| Breast Cancer |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Antibiotic Therapy |
2.1% |
| Cardiac Failure |
2.1% |
| Depression |
1.9% |
| Neuralgia |
1.9% |
| Osteopenia |
1.9% |
|
| Neutropenia |
8.9% |
| Renal Failure |
8.9% |
| Renal Failure Acute |
7.6% |
| Tongue Oedema |
6.3% |
| Viral Infection |
6.3% |
| Gastrointestinal Haemorrhage |
5.1% |
| Thrombocytopenia |
5.1% |
| Visual Brightness |
5.1% |
| Vomiting |
5.1% |
| Confusional State |
3.8% |
| Diarrhoea |
3.8% |
| Hyponatraemia |
3.8% |
| Infection |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Myalgia |
3.8% |
| Pleural Effusion |
3.8% |
| Pulmonary Arterial Hypertension |
3.8% |
| Tremor |
3.8% |
| Urinary Tract Infection |
3.8% |
| Urticaria |
3.8% |
|
